Updated Oct 9, 2026 · 04:30 UTC
LLYEli Lilly And Co
Health Care · United States · XNYS · pharmaceutical preparations
$1,166.28−1.61%last session · market closed
Market cap
$1.04t
real-world
Tokenized
$8.5m
<0.001% of the asset
Avg token price
$1,169.92
+0.31% vs real
Spot volume, 24h
$5.1m
28 venues
Derivatives, 24h
$25.8m
0.9% of real volume
Perp open interest
$21.9m
33 venues
In DeFi
$103k
2 pools
LLY · Price
Sep 5, 2025low $719.33 · high $1,284.05 · now $1,163.66Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $9.83 (4 analysts)
Last earnings, Aug 5
$8.38 EPS
+39.4% vs $6.01 forecast · Jun 2026 quarter
Real market
Eli Lilly & Co.
Last close
$1,188.72
Oct 7
Traded on Oct 7
$2.74b
Price now
$1,166.28
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $5.1m · 28 venues
Uniswap V3 (Robinhood)4 pairs$1.1m
KCEX1 pair$1.0m
YUBIT1 pair$530kDerivatives · $25.8m · 33 venues · $21.9m open interest
Binance1 pair · OI $2.7m · funding +0.0201%$5.8m
Ourbit1 pair · OI $158k · funding +0.0199%$3.9m
EasiCoin1 pair · OI $306k · funding +0.0100%$2.2mOnchain versions
7 tokens from 6 issuers
LLYonOndo Assets$1,171.41$5.1m
LLYBbStocks$1,167.25$1.2m
LLYXBacked Assets$1,169.76$1.1m
LLYRobinhood$1,167.91$1.0m
rLLYReality$1,165.65$50k
LLYcCoinbase$1,124.88$49k
WLLYXBacked Assets$1,172.55$13kBy chain
Where the tokens circulate, issuers’ unsold stock taken off
Ethereum57%$4.8m
BNB Chain17%$1.4m
Solana13%$1.1m
Robinhood Chain12%$1.0m
Arbitrum0.6%$50k
Base0.6%$49k
X Layer0.2%$13k
Ink0.1%$11kIn DeFi
2 pools and lending markets · $103k including paired assets
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$79.67b
+50% YoY
Net income
$26.71b
34% margin · +94% YoY
EPS, diluted
$29.89
+95% YoY
Cash and balance sheet
Free cash flow
$18.19b
23% of revenue
Net debt
$45.96b
$8.95b cash and securities, $54.91b debt
Diluted shares
894m
−1% YoY
Valuation at today’s market cap
P/E
39×
EV / sales
13.6×
enterprise value $1.09t
Free cash flow yield
1.7%
Quarterly
RevenueNet income